XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information
 6 Months Ended
Jun. 27, 2025
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in two business segments, the Specialty Products & Technologies and Equipment & Consumables segments. The Company’s Specialty Products & Technologies products primarily include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products primarily include traditional consumable products such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products primarily include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2024, the Company adopted ASU 2023-07, “Segment Reporting - Improving Reportable Segment Disclosures” and updated its disclosures to conform to the new segment disclosure requirements. Additionally, prior year disclosures have been modified to conform to the new ASU disclosure presentation requirements.

The Company’s operating segments are also its reportable segments. The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM primarily utilizes segment operating profit or loss as the key indicator in assessing the segment's performance and allocating resources. Operating profit represents total revenues less expenses, excluding corporate and other expenses, nonoperating income (expense), interest expense and income taxes. The expense components used in determining operating profit include the following:

Cost of sales which include the cost of materials, labor, facilities, restructuring costs and other infrastructure used to manufacture the Company’s products, and shipping and handling costs attributable to delivering these products to customers.

SG&A expenses which includes, among other things, the costs of selling, marketing, promotion, advertising and administration (including business technology, facilities, legal, finance, human resources, business development and procurement), restructuring costs, and amortization expense for intangible assets that have been acquired through business combinations.

Research and development (“R&D”) expenses which include project costs specific to new product R&D and product lifecycle management, overhead costs associated with R&D operations, regulatory costs, product registrations and investments that support local market clinical trials for approved indications.

For corporate and other, these expenses represent unallocated corporate costs and other costs, including goodwill and intangible impairment charges. These activities do not meet the criteria for a stand-alone reporting segment under ASC 280 Segment Reporting, thus are not considered in management’s evaluation of reportable segment operating performance.

The identifiable assets by segment are those used in each segment’s operations. Additionally, inter-segment amounts which have been eliminated, are not significant to the below presentation of segment information.
Segment related information is shown below ($ in millions):
Three Months Ended June 27, 2025Three Months Ended June 28, 2024
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Sales$445.1 $237.0 $682.1 $415.1 $218.0 $633.1 
Less:
Expenses399.8 200.9 600.7 409.1 191.5 600.6 
Segment operating profit$45.3 $36.1 $81.4 $6.0 $26.5 $32.5 
Segment operating profit and reconciliation to income (loss) before taxes:
Segment operating profit$81.4 $32.5 
Corporate and other(35.1)(1,185.8)
Nonoperating other income (expense), net2.4 (1.1)
Interest expense, net(8.0)(11.7)
Income (loss) before taxes$40.7 $(1,166.1)
Depreciation and amortization
Specialty Products & Technologies$22.0 $22.5 
Equipment & Consumables7.4 10.9 
Corporate and other0.4 0.6 
Total$29.8 $34.0 
Capital expenditures, gross
Specialty Products & Technologies$6.7 $5.4 
Equipment & Consumables4.4 0.9 
Corporate and other(0.2)0.8 
Total$10.9 $7.1 
Six Month Period Ended June 27, 2025Six Month Period Ended June 28, 2024
Specialty Products & TechnologiesEquipment & ConsumablesTotalSpecialty Products & TechnologiesEquipment & ConsumablesTotal
Sales$845.4 $453.6 $1,299.0 $823.8 $432.9 $1,256.7 
Less:
Expenses762.5 385.6 1,148.1 773.6 370.8 1,144.4 
Segment operating profit$82.9 $68.0 $150.9 $50.2 $62.1 $112.3 
Segment operating profit and reconciliation to income (loss) before taxes:
Segment operating profit$150.9 $112.3 
Corporate and other(65.6)(1,217.5)
Nonoperating other income (expense), net1.7 (1.0)
Interest expense, net(17.3)(24.6)
Income (loss) before taxes$69.7 $(1,130.8)
Depreciation and amortization
Specialty Products & Technologies$42.6 $43.1 
Equipment & Consumables14.3 21.8 
Corporate and other0.8 1.2 
Total$57.7 $66.1 
Capital expenditures, gross
Specialty Products & Technologies$10.4 $11.8 
Equipment & Consumables7.9 4.6 
Corporate and other0.1 1.6 
Total$18.4 $18.0 

Identifiable assetsJune 27, 2025December 31, 2024
Specialty Products & Technologies$2,492.3 $2,354.2 
Equipment & Consumables2,018.1 1,884.2 
Corporate and other1,154.0 1,112.1 
Total$5,664.4 $5,350.5